Department of Pathology, Division of Renal and Transplant Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Department of Internal Medicine, Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
PLoS One. 2018 Apr 10;13(4):e0193274. doi: 10.1371/journal.pone.0193274. eCollection 2018.
Small glomerular IgA deposits have been reported in patients with liver cirrhosis, mainly as an incidental finding in autopsy studies. We recently encountered nine cirrhotic patients who presented with acute proliferative glomerulonephritis with unusually large, exuberant glomerular immune complex deposits, in the absence of systemic lupus erythematosus (SLE) or monoclonal gammopathy-related kidney disease. Deposits were typically IgA dominant/codominant. Our aim was to further elucidate the etiology, diagnostic pitfalls, and clinical outcomes.
We present clinical features and kidney biopsy findings of nine cirrhotic patients with an unusual acute immune complex glomerulonephritis. We also identified native kidney biopsies from all patients with liver cirrhosis at our institution over a 13-year period (January 2004 to December 2016) to evaluate presence of glomerular IgA deposits in them (n = 118).
Six of nine cirrhotic patients with the large immune deposits had a recent/concurrent acute bacterial infection, prompting a diagnosis of infection-associated glomerulonephritis and treatment with antibiotics. In the remaining three patients, no infection was identified and corticosteroids were initiated. Three of nine patients recovered kidney function (one recovered kidney function after liver transplant); three patients developed chronic kidney disease but remained off dialysis; two patients became dialysis-dependent and one patient developed sepsis and expired shortly after biopsy. Within the total cohort of 118 patients with cirrhosis, 67 others also showed IgA deposits, albeit small; and 42 patients had no IgA deposits.
These cases provide support to the theory that liver dysfunction may compromise clearance of circulating immune complexes, enabling deposition in the kidney. At least in a subset of cirrhotic patients, a superimposed bacterial infection may serve as a "second-hit" and lead to acute glomerulonephritis with exuberant immune complex deposits. Therefore, a trial of antibiotics is recommended and caution is advised before immunosuppressive treatment is offered. Unfortunately, most of these patients have advanced liver failure; therefore both diagnosis and management remain a challenge.
已有研究报告称,在肝硬化患者中存在小的肾小球 IgA 沉积,主要为尸检研究中的偶然发现。我们最近遇到了 9 例肝硬化患者,这些患者表现为急性增生性肾小球肾炎,伴有异常大量、丰富的肾小球免疫复合物沉积,且无系统性红斑狼疮(SLE)或单克隆丙种球蛋白相关性肾脏病。沉积物通常以 IgA 为主/优势。我们旨在进一步阐明病因、诊断陷阱和临床结局。
我们介绍了 9 例肝硬化患者伴有不寻常的急性免疫复合物性肾小球肾炎的临床特征和肾活检结果。我们还从我们机构在 13 年期间(2004 年 1 月至 2016 年 12 月)获得的所有肝硬化患者的肾活检标本中,评估了他们肾小球 IgA 沉积的存在(n = 118)。
9 例大免疫沉积物的肝硬化患者中,有 6 例有近期/同时的急性细菌感染,提示诊断为感染相关性肾小球肾炎,并给予抗生素治疗。在其余 3 例患者中,未发现感染,开始使用皮质类固醇治疗。9 例患者中有 3 例恢复了肾功能(1 例在肝移植后恢复了肾功能);3 例患者发展为慢性肾脏病,但仍未接受透析;2 例患者依赖透析,1 例患者发生败血症,活检后不久即死亡。在 118 例肝硬化患者的总队列中,另外 67 例患者也有小的 IgA 沉积;42 例患者无 IgA 沉积。
这些病例为肝功能障碍可能会损害循环免疫复合物的清除能力,从而导致其在肾脏沉积的理论提供了支持。至少在一部分肝硬化患者中,叠加的细菌感染可能作为“二次打击”,导致丰富的免疫复合物沉积的急性肾小球肾炎。因此,建议进行抗生素试验,并在给予免疫抑制治疗之前谨慎行事。不幸的是,这些患者大多有晚期肝功能衰竭;因此,诊断和治疗仍然是一个挑战。